glp-1 anesthesia guidelines 2025 Are Serious Risks of Semaglutide and Other Agonists Under-Recognized? Case Reports of Retained Solid Gastric Contents in Patients Undergoing Anesthesia GLP-1 RA guidance roundup -

As he says 'No similar treatment outcome had ever been seen before, and the significance of this result cannot be overstated

EE energy expenditure, NR not reported, NS non-significant a Based on results for ad libitum lunch b Results are for liraglutide 3.0 mg Clinical Trials Demonstrating Reductions in Body Weight with GLP-1RAs Several clinical trials have reported that the effects described above resulted in larger reductions in body weight with GLP-1RA therapy compared with placebo in participants with obesity

This guide covers exactly what GLP-1 friendly meals look like in practice

Orforglipron, an oral Small-Molecule GLP-1 receptor agonist for obesity treatment

Maintaining weight loss If you are prescribed a weight-loss medication, board-certified providers will continue to evaluate you and may slowly adjust the dose about every four weeks to find the right dose that works best for you

Busso N, Wagtmann N, Herling C, Chobaz-Pclat V, Bischof-Delaloye A, So A, et al